Insights On Enterprise Solutions

  1. Behind The Data: Next‑Generation Enzymes For Targeted Gene Insertion 9/23/2026

    Large serine recombinases enable efficient insertion of sizable genetic cargo without exposed double-strand breaks, creating new opportunities for precise engineering in therapeutically relevant cells.

  2. Behind The Data: Engineering Hepatocyte-Targeted LNPs 9/23/2026

    See how lipid nanoparticle platforms can deliver RNA and large DNA payloads to primary human T cells, improving transfection, expression durability, and CAR insertion efficiency.

  3. Behind The Data: Comprehensive Off-Target Assessment Strategies 9/23/2026

    Explore how biochemical, computational, and cell-based methods can identify, confirm, and interpret off-target editing risks, providing a more complete safety assessment for CRISPR-based therapeutics.

  4. Behind The Data: Iterative Engineering And Optimization Strategies 9/23/2026

    See how iterative optimization across RNA chemistry, lipid nanoparticle formulation, protein engineering, and preclinical testing can improve in vivo liver editing potency and accelerate progression.

  5. De-Risking The Path To GMP Manufacturing At Another Organization 9/23/2026

    Successful tech transfer depends on more than moving a process. Early alignment across process readiness, analytical strategy, governance, and decision-making helps reduce execution risk.

  6. Breaking The GLP-1 Manufacturing Bottleneck: Single Use For Safer Scale Up 9/23/2026

    Streamline GLP-1 scale-up by replacing heavy container cleaning with single-use powder handling to boost containment and manufacturing capacity.

  7. Optimizing Gene Knockdown And In Vivo Base Editing 9/22/2026

    See how complementary CRISPR systems, broad guide RNA screening, and chemical modifications improved editing potency and stability, producing strong correlations among editing.

  8. A Novel Non-Viral Platform For High-Efficiency T-Cell Engineering 9/22/2026

    Gain insight into how nuclease format, delivery method, and DNA template design influence knockout efficiency, targeted TCR integration, cell viability, and recovery.

  9. Versatile And Robust Epigenetic Modulation Platform 9/22/2026

    Discover how RNA-guided epigenetic editing enables durable, tunable, and multiplexed gene regulation without altering DNA, while demonstrating broad delivery flexibility and strong on-target specificity.

  10. Perfusion Cultivations With NIST CHO Cells Using The Multifors 3 Bioreactor 9/22/2026

    Execute stable long-term perfusion with automated volume, feed, and biomass control. Maintain cell viability and high volumetric productivity with integrated bioreactor systems.